CLSA Downgrades Bristol-Myers Squibb Co. (BMY) to Underperform
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $48.99 --0%
Rating Summary:
6 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 14
Rating Summary:
6 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 14
Join SI Premium – FREE
CLSA downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Underperform, price target upped $2 to $35.00.
For more ratings news on Bristol-Myers Squibb Co. click here and for the rating history of Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $32.62 yesterday.
For more ratings news on Bristol-Myers Squibb Co. click here and for the rating history of Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $32.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Downgrades Molson Coors (TAP) to Sell, 'Cycling 2023 Could Be a Mountain Too Hard to Climb'
- Oppenheimer Downgrades MSCI Inc. (MSCI) to Perform
- Benchmark Downgrades Hibbett Sports (HIBB) to Hold
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
